Literature DB >> 3855324

An in vivo model for squamous cell carcinoma of the head and neck.

S R Baker.   

Abstract

In recent years, the successful grafting of human tumors into immune deprived animals has spurred the hopes of developing a reliable in vivo model for evaluation of human cancer. The nude mouse has created new perspectives in many different areas of cancer research, and has proved to be the most useful recipient of any animal system for tumor heterotransplantation. This study determined which of several squamous cell carcinoma (SCC) cell lines would reproducibly grow as heterotransplants in nude mice, and allowed an opportunity to determine whether characteristics of the tumor changed as a result of propagation in tissue culture. Sixteen (76%) of the 21 SCC lines heterotransplanted in nude mice remained as viable tumor nodules. Nine (43%) of these lines reproducibly produced progressively enlarging tumor masses. Five (24%) SCC lines failed to grow as heterotransplants. The average lag phase between implantation and the beginning of growth for all SCC lines tested was approximately 7 weeks and emphasizes the need for prolonged observation of nude mice following SCC heterotransplantation. The rate and pattern of growth of SCC in nude mice appears to be related specifically to the tumorigenic factors of a given cell line. The concurrent presence of other SCC or non-SCC tumors in a given mouse do not appear to influence the growth of a specific cell line. In addition, specific host factors that might vary from one mouse to another did not alter the growth patterns of SCC. Histological examination of the SCC lines successfully heterotransplanted in nude mice showed similar histological appearances to the original tumor in the human host.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855324     DOI: 10.1288/00005537-198501000-00012

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation.

Authors:  M J Worsham; S R Wolman; T E Carey; R J Zarbo; M S Benninger; D L Van Dyke
Journal:  Mol Pathol       Date:  1999-02

2.  The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.

Authors:  Somaira Nowsheen; James A Bonner; Eddy S Yang
Journal:  Radiother Oncol       Date:  2011-06-28       Impact factor: 6.280

3.  Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors.

Authors:  R J Tatake; N Rajaram; R N Damle; B Balsara; A N Bhisey; S G Gangal
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  DNA ploidy and protein synthesis in squamous cell carcinoma cell lines of the head and neck.

Authors:  T Görögh; B M Lippert; E Sprenger; S Saffran; K Heidorn; G Bergmann; E Henze; J A Werner
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility.

Authors:  Dawn Katafiasz; Lynette M Smith; James K Wahl
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

6.  Determination of subcutaneous tumor size in athymic (nude) mice.

Authors:  M M Tomayko; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Detection of differentially expressed basal cell proteins by mass spectrometry.

Authors:  Viktor Todorović; Bhushan V Desai; Richard A Eigenheer; Taofei Yin; Evangeline V Amargo; Milan Mrksich; Kathleen J Green; Melanie J Schroeder Patterson
Journal:  Mol Cell Proteomics       Date:  2009-11-30       Impact factor: 5.911

Review 8.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 9.  Xenograft models of head and neck cancers.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Head Neck Oncol       Date:  2009-08-13

10.  Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.

Authors:  Somaira Nowsheen; James A Bonner; Albert F Lobuglio; Hoa Trummell; Alexander C Whitley; Michael C Dobelbower; Eddy S Yang
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.